Atlas Trials

Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy

Clinical trial NCT03025399 · UNKNOWN

Trial details

NCT number
NCT03025399
Sponsor
Fengmei Lian
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Diabetic Non-proliferative RetinopathyType2 Diabetes
Start date
2017-02-01
Primary completion
2019-05-01
Enrollment
384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.